Previous Article | Next Article 
Journal of Virology, July 1999, p. 5431-5437, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Identification of a Cytoplasmic Targeting/Retention
Signal in a Retroviral Gag Polyprotein
Gyu
Choi,1
Sunyoung
Park,1
Bongkun
Choi,1
Suntaek
Hong,1
Jiyeon
Lee,1
Eric
Hunter,2 and
Sung S.
Rhee1,*
Laboratory of Molecular Virology, Samsung
Biomedical Research Institute, Seoul, Korea,1
and Department of Microbiology, University of Alabama at
Birmingham, Birmingham, Alabama 352942
Received 19 January 1999/Accepted 24 March 1999
Retroviral capsid assembly can occur by either of two distinct
morphogenic processes: in type C viruses, the capsid assembles and buds
at the plasma membrane, while in type B and D viruses, the capsid
assembles within the cytoplasm and is then transported to the plasma
membrane for budding. We have previously reported that a
single-amino-acid substitution of a tryptophan for an arginine in the
matrix protein (MA) of Mason-Pfizer monkey virus (MPMV) converts its
capsid assembly from that of a type D retrovirus to that of the type C
viruses (S. S. Rhee and E. Hunter, Cell 63:77-86, 1990). Here we
identify a region of 18 amino acids within the MA of MPMV that is
responsible for type D-specific morphogenesis. Insertion of these 18 amino acids into the MA of type C Moloney murine leukemia virus causes
it to assemble an immature capsid in the cytoplasm. Furthermore, fusion
of the MPMV MA to the green fluorescent protein resulted in altered
intracellular targeting and a punctate accumulation of the fusion
protein in the cytoplasm. These 18 amino acids, which are necessary and
sufficient to target retroviral Gag polyproteins to defined sites in
the cytoplasm, appear to define a novel mammalian cytoplasmic
targeting/retention signal.
*
Corresponding author. Mailing address: Laboratory of
Molecular Virology, Samsung Biomedical Research Institute, Kangnam-Ku, Ilwon-Dong 50, Seoul 135-230, Korea. Phone: 82-2-3410-3632. Fax: 82-2-3410-3649. E-mail: ssrhee{at}smc.samsung.co.kr.
Journal of Virology, July 1999, p. 5431-5437, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vlach, J., Lipov, J., Rumlova, M., Veverka, V., Lang, J., Srb, P., Knejzlik, Z., Pichova, I., Hunter, E., Hrabal, R., Ruml, T.
(2008). D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein. Proc. Natl. Acad. Sci. USA
105: 10565-10570
[Abstract]
[Full Text]
-
Life, R. B., Lee, E.-G., Eastman, S. W., Linial, M. L.
(2008). Mutations in the Amino Terminus of Foamy Virus Gag Disrupt Morphology and Infectivity but Do Not Target Assembly. J. Virol.
82: 6109-6119
[Abstract]
[Full Text]
-
Arnaud, F., Murcia, P. R., Palmarini, M.
(2007). Mechanisms of Late Restriction Induced by an Endogenous Retrovirus. J. Virol.
81: 11441-11451
[Abstract]
[Full Text]
-
Gill, M. B., Kutok, J. L., Fingeroth, J. D.
(2007). Epstein-Barr Virus Thymidine Kinase Is a Centrosomal Resident Precisely Localized to the Periphery of Centrioles. J. Virol.
81: 6523-6535
[Abstract]
[Full Text]
-
Mannigel, I., Stange, A., Zentgraf, H., Lindemann, D.
(2007). Correct Capsid Assembly Mediated by a Conserved YXXLGL Motif in Prototype Foamy Virus Gag Is Essential for Infectivity and Reverse Transcription of the Viral Genome. J. Virol.
81: 3317-3326
[Abstract]
[Full Text]
-
Murcia, P. R., Arnaud, F., Palmarini, M.
(2007). The Transdominant Endogenous Retrovirus enJS56A1 Associates with and Blocks Intracellular Trafficking of Jaagsiekte Sheep Retrovirus Gag. J. Virol.
81: 1762-1772
[Abstract]
[Full Text]
-
Bauerova-Zabranska, H., Stokrova, J., Strisovsky, K., Hunter, E., Ruml, T., Pichova, I.
(2005). The RNA Binding G-patch Domain in Retroviral Protease Is Important for Infectivity and D-type Morphogenesis of Mason-Pfizer Monkey Virus. J. Biol. Chem.
280: 42106-42112
[Abstract]
[Full Text]
-
Cartellieri, M., Herchenroder, O., Rudolph, W., Heinkelein, M., Lindemann, D., Zentgraf, H., Rethwilm, A.
(2005). N-Terminal Gag Domain Required for Foamy Virus Particle Assembly and Export. J. Virol.
79: 12464-12476
[Abstract]
[Full Text]
-
Stansell, E., Tytler, E., Walter, M. R., Hunter, E.
(2004). An Early Stage of Mason-Pfizer Monkey Virus Budding Is Regulated by the Hydrophobicity of the Gag Matrix Domain Core. J. Virol.
78: 5023-5031
[Abstract]
[Full Text]
-
Lecellier, C.-H., Neves, M., Giron, M.-L., Tobaly-Tapiero, J., Saib, A.
(2002). Further Characterization of Equine Foamy Virus Reveals Unusual Features among the Foamy Viruses. J. Virol.
76: 7220-7227
[Abstract]
[Full Text]
-
Wilk, T., Geiselhart, V., Frech, M., Fuller, S. D., Flugel, R. M., Lochelt, M.
(2001). Specific Interaction of a Novel Foamy Virus Env Leader Protein with the N-Terminal Gag Domain. J. Virol.
75: 7995-8007
[Abstract]
[Full Text]
-
Eastman, S. W., Linial, M. L.
(2001). Identification of a Conserved Residue of Foamy Virus Gag Required for Intracellular Capsid Assembly. J. Virol.
75: 6857-6864
[Abstract]
[Full Text]
-
Tobaly-Tapiero, J., Bittoun, P., Giron, M.-L., Neves, M., Koken, M., Saïb, A., de Thé, H.
(2001). Human Foamy Virus Capsid Formation Requires an Interaction Domain in the N Terminus of Gag. J. Virol.
75: 4367-4375
[Abstract]
[Full Text]
-
Rumlova-Klikova, M., Hunter, E., Nermut, M. V., Pichova, I., Ruml, T.
(2000). Analysis of Mason-Pfizer Monkey Virus Gag Domains Required for Capsid Assembly in Bacteria: Role of the N-Terminal Proline Residue of CA in Directing Particle Shape. J. Virol.
74: 8452-8459
[Abstract]
[Full Text]
-
Ono, A., Orenstein, J. M., Freed, E. O.
(2000). Role of the Gag Matrix Domain in Targeting Human Immunodeficiency Virus Type 1 Assembly. J. Virol.
74: 2855-2866
[Abstract]
[Full Text]
-
Parker, S. D., Hunter, E.
(2000). A Cell-Line-Specific Defect in the Intracellular Transport and Release of Assembled Retroviral Capsids. J. Virol.
74: 784-795
[Abstract]
[Full Text]
-
Sakalian, M., Hunter, E.
(1999). Separate Assembly and Transport Domains within the Gag Precursor of Mason-Pfizer Monkey Virus. J. Virol.
73: 8073-8082
[Abstract]
[Full Text]